Beskrywing

According to a report by StrategyHelix, the global 3d bioprinting market is set to increase by US$ 1,538.1 miljoen tydens 2022-2028, growing at a CAGR of 17.3% gedurende die voorspellingsperiode.

Die verslag verskaf up-to-date markgrootte data vir tydperk 2018-2021 en voorspel tot 2028 covering key market aspects like sales value for 3d bioprinting. The global 3d bioprinting market is segmented on the basis of components, tegnologie, material, aansoek, end user, en streek. On the basis of components, the global 3d bioprinting market has been segmented into 3D bioprinters, bioinks. By technology, the global 3d bioprinting market has been segmented into inkjet bioprinting, laser assisted bioprinting, magnetic levitation bioprinting, syringe/extrusion bioprinting, ander. Based on material, the global 3d bioprinting market is categorized into extracellular matrices, hydrogels, living cells, ander. On the basis of application, the global 3d bioprinting market has been segmented into clinical, navorsing. By end user, the global 3d bioprinting market has been segmented into biopharmaceutical companies, regenerative medicine companies, research organizations & academic institutes, ander. Geografies, the global 3d bioprinting market is segmented into Asia Pacific, Europa, Noord-Amerika, Rest of the World (RoW).

The global 3d bioprinting market is highly competitive. The prominent players operating in the global 3d bioprinting market include 3D Systems Corporation (Allevi Inc.), Advanced Solutions Life Sciences LLC (ASLS), Aspect Biosystems Ltd., BICO Group AB (Formerly Cellink AB), Cyfuse Biomedical K.K., EnvisionTEC GmbH (Desktop Metal Inc.), GeSIM GmbH, Inventia Life Science Pty Ltd., Nano3D Biosciences Inc. (n3D), Organovo Holdings Inc., Poietis SAS, regenHU Ltd., Regenovo Biotechnology Co. Bpk., ROKIT Healthcare INC., Stratasys Ltd., Vivax Bio LLC (3D Bioprinting Solutions). Competitive landscape gives a description of the competitive nature of the global 3d bioprinting market and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

Die verslag is 'n waardevolle hulpbron vir maatskappye en organisasies wat in hierdie bedryf aktief is. It provides a cohesive picture of the 3d bioprinting market to help drive informed decision making for industry executives, beleidmakers, akademies, en ontleders.

Verslag Omvang

Components: 3D bioprinters, bioinks
Tegnologie: inkjet bioprinting, laser assisted bioprinting, magnetic levitation bioprinting, syringe/extrusion bioprinting, ander
Material: extracellular matrices, hydrogels, living cells, ander
Toepassing: clinical, navorsing
End user: biopharmaceutical companies, regenerative medicine companies, research organizations & academic institutes, ander
Streek: Asiatiese Stille-Oseaan, Europa, Noord-Amerika, Rest of the World (RoW)
Jare oorweeg: hierdie verslag dek die tydperk 2018 aan 2028
Company mentioned: 3D Systems Corporation (Allevi Inc.), Advanced Solutions Life Sciences LLC (ASLS), Aspect Biosystems Ltd., BICO Group AB (Formerly Cellink AB), Cyfuse Biomedical K.K., EnvisionTEC GmbH (Desktop Metal Inc.), GeSIM GmbH, Inventia Life Science Pty Ltd., Nano3D Biosciences Inc. (n3D), Organovo Holdings Inc., Poietis SAS, regenHU Ltd., Regenovo Biotechnology Co. Bpk., ROKIT Healthcare INC., Stratasys Ltd., Vivax Bio LLC (3D Bioprinting Solutions)

Sleutelvoordele vir belanghebbendes

– Get a comprehensive picture of the global 3d bioprinting market
– Identifiseer streekstrategieë en strategiese prioriteite op grond van plaaslike data
– Bepaal groeisektore en -neigings vir belegging

INHOUDSOPGAWE

Deel 1. Inleiding
– Omvang van die studie
– Studietydperk
– Geografiese omvang
– Navorsingsmetodologie
Deel 2. 3d bioprinting market overview
Deel 3. Market breakdown by components
– 3D bioprinters
– Bioinks
Deel 4. Market breakdown by technology
– Inkjet bioprinting
– Laser assisted bioprinting
– Magnetic levitation bioprinting
– Syringe/extrusion bioprinting
– Ander
Deel 5. Market breakdown by material
– Extracellular matrices
– Hydrogels
– Living cells
– Ander
Deel 6. Markverdeling volgens toepassing
– Clinical
– Research
Deel 7. Market breakdown by end user
– Biopharmaceutical companies
– Regenerative medicine companies
– Research organizations & academic institutes
– Ander
Deel 8. Market breakdown by region
– Asiatiese Stille-Oseaan
– Europa
– Noord-Amerika
– Rest of the World (RoW)
Deel 9. Sleutel maatskappye
– 3D Systems Corporation (Allevi, Inc.)
– Advanced Solutions Life Sciences, LLC (ASLS)
– Aspect Biosystems Ltd.
– BICO Group AB (Formerly Cellink AB)
– Cyfuse Biomedical K.K.
– EnvisionTEC GmbH (Desktop Metal Inc.)
– GeSIM GmbH
– Inventia Life Science Pty Ltd.
– Nano3D Biosciences, Inc. (n3D)
– Organovo Holdings Inc.
– Poietis SAS
– regenHU Ltd.
– Regenovo Biotechnology Co., Bpk.
– ROKIT Healthcare, INC.
– Stratasys Ltd.
– Vivax Bio, LLC (3D Bioprinting Solutions)
Oor StrategyHelix
Vrywaring